Department of Health
and Human Services (HHS)
and Human Services (HHS)
February 9, 2024
National Institute of Neurological Disorders and Stroke (NINDS)
National Eye Institute (NEI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Center for Complementary and Integrative Health (NCCIH)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Office of Behavioral and Social Sciences Research (OBSSR)
The purpose of this notice is to inform applicants of an extension to PAR-21-233 “Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)”. The following application due dates have been added: July 15, 2024, AIDS Application Due Date: August 19, 2024, Expiration Date: August 20, 2024. Changes to this notice of funding opportunity (NOFO) are shown below.
Currently Reads:
| Application Due Date(s) | August 10, 2021, February 9, 2022, August 9, 2022, February 9, 2023, August 9, 2023, February 9, 2024 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) | September 5, 2021, April 5, 2022, September 5, 2022, April 5, 2023, September 5, 2023, April 5, 2024 All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | November 2021, June 2022, November 2022, June 2023, November 2023, June 2024 |
| Advisory Council Review | January 2022, October 2022, January 2023, October 2023, January 2024, October 2024 |
| Earliest Start Date | April 2022 |
| Expiration Date | April 06, 2024 |
Modified to Read:
| Application Due Date(s) | August 10, 2021, February 9, 2022, August 9, 2022, February 9, 2023, August 9, 2023, February 9, 2024, July 15, 2024 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) | September 5, 2021, April 5, 2022, September 5, 2022, April 5, 2023, September 5, 2023, April 5, 2024, August 19, 2024 All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | November 2021, June 2022, November 2022, June 2023, November 2023, June 2024, November 2024 |
| Advisory Council Review | January 2022, October 2022, January 2023, October 2023, January 2024, October 2024, January 2025 |
| Earliest Start Date | April 2022 |
| Expiration Date | August 20, 2024 |
All other aspects of this NOFO remain unchanged.
Chris Boshoff, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]